scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

NEXT STORY
Ascendis Pharma A/S Presents 6-Month Open-Label Extension Data from Phase 2 PaTH Forward Trial of TransCon PTH in Adult Hypoparathyroidism at ENDO 2021
PREV STORY
Vision Care Market 2021 | To Exhibit a CAGR of 5.6% and Hit USD 192.85 Billion by 2026
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TRACON Pharmaceuticals Announces Appointment of Brian Daniels, M.D., to Scientific Advisory Board

SAN DIEGO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage ...

author_avatar
NASDAQ Market News

Nohla Therapeutics Appoints Kathleen Fanning as President and Chief Executive Officer

SEATTLE, Feb. 02, 2017 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a leading developer ...

author_avatar
NASDAQ Market News

Rafael Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference

Newark, NJ, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael”), a leader ...

author_avatar
NASDAQ Market News